"Since the inception of our PERT team, we have been looking for ways to leverage advanced technologies to improve patient outcomes. Collaborating with RapidAI has allowed us to utilize their platform, first used to streamline the workflow in stroke, and bring this technology into the pulmonary embolism space. RapidAI will allow us to advance diagnostics, treatment algorithms, and communications across multiple providers and facilities," said Dr. Jay Mathews, Director Cardiac Catheterization Lab, Structural Heart, and PERT at Manatee Memorial Hospital.
About RapidAI
RapidAI is the global leader using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into full focus. Based on intelligence gained from over 2 million scans in more than 1,800 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.
Back to HCB News
